acetylcysteine has been researched along with amphotericin b in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
| Chen, F; Hu, L; Lan, L; Li, B; Li, J; Mao, F; Ni, S; Qiu, X; Wang, M; Wei, H; Zheng, X; Zhu, J | 1 |
| Albelda, SM; Mayock, RL; McLean, GK; Shapiro, MJ | 1 |
| Lin, MC; Ou, CC; Tsao, SM; Yin, MC | 1 |
| Kellum, J; Leblanc, M; Venkataraman, R | 2 |
| Venkataraman, R | 1 |
| Brincat, S; Hilton, R | 1 |
| Aslam, S; Darouiche, RO; Hernandez, MD; Mansouri, MD; Zeluff, B | 1 |
| Cermik, H; Karaalp, A; Koc, M; Korten, V; Mohr, J; Odabasi, Z; Tigen, ET | 1 |
| Jiang, HN; Qu, JM; Xu, JF; Xu, P; Zhang, HJ; Zhang, J | 1 |
| Albert, N; Kontoyiannis, DP; Lewis, RE; Pontikos, MA; Shirazi, F; Walsh, TJ | 1 |
| Abdollahi, A; Dashti-Khavidaki, S; Farsaei, S; Hasibi, M; Karimzadeh, I; Khalili, H; Khazaeipour, Z; Sharifian, R | 1 |
| Farsaei, S; Karimzadeh, I; Khalili, H; Sagheb, MM | 1 |
| Carmo, PHF; Carvalho, VSD; Costa, MC; de Brito, CB; de Resende-Stoianoff, MA; de Souza, DG; Emídio, ECP; Ferreira, GF; Freitas, GJC; Holanda, RA; Magalhães, TFF; Paixão, TA; Ribeiro, NQ; Rocha, CEV; Santos, DA | 1 |
5 review(s) available for acetylcysteine and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Theophylline | 2005 |
Renal failure (acute).
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Aminophylline; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Theophylline | 2006 |
Can we prevent acute kidney injury?
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Contrast Media; Critical Care; Dehydration; Free Radical Scavengers; Humans; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors | 2008 |
Prevention of acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Allopurinol; Aminoglycosides; Amphotericin B; Antifungal Agents; Contrast Media; Dehydration; Dopamine Agonists; Glomerular Filtration Rate; Humans; Hypovolemia; Natriuretic Peptides; Renal Agents; Renal Circulation; Sodium Potassium Chloride Symporter Inhibitors; Theophylline | 2008 |
2 trial(s) available for acetylcysteine and amphotericin b
| Article | Year |
|---|---|
N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances: a randomized, double-blinded, placebo-controlled, clinical trial.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Water-Electrolyte Imbalance; Young Adult | 2014 |
A double-blinded, placebo-controlled, multicenter clinical trial of N-acetylcysteine for preventing amphotericin B-induced nephrotoxicity.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cystatin C; Double-Blind Method; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Kidney Diseases; Kidney Function Tests; Male; Membrane Glycoproteins; Middle Aged; Receptors, Virus; Young Adult | 2015 |
14 other study(ies) available for acetylcysteine and amphotericin b
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Oxidoreductases; Piperonyl Butoxide; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2018 |
Severe hemoptysis associated with pulmonary aspergilloma. Percutaneous intracavitary treatment.
Topics: Acetylcysteine; Aminocaproates; Amphotericin B; Aspergillosis; Catheterization; Catheters, Indwelling; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Male; Middle Aged | 1988 |
Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic.
Topics: Acetylcysteine; Allyl Compounds; Amphotericin B; Antioxidants; Chelating Agents; Copper; Cysteine; Disulfides; Edetic Acid; Garlic; Glucose; Humans; Lipoproteins, LDL; Oxidation-Reduction; Sulfides; Sulfur Compounds; Superoxides; Xanthine Oxidase | 2003 |
Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices.
Topics: Acetylcysteine; Amphotericin B; Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Disease Models, Animal; Equipment Contamination; Gentamicins; Heart-Assist Devices; Humans; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2009 |
Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine.
Topics: Acetylcysteine; Amphotericin B; Animals; Anti-Bacterial Agents; Antiviral Agents; Apoptosis; Kidney; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley | 2009 |
NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model.
Topics: Acetylcysteine; Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Humans; Interleukin-10; Invasive Pulmonary Aspergillosis; Lung Injury; Male; Mice; Mice, Inbred BALB C; Neutropenia; Oxidative Stress; Random Allocation; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2009 |
Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.
Topics: Acetylcysteine; Amphotericin B; Antifungal Agents; Apoptosis; Caspases; Free Radical Scavengers; Hot Temperature; Humans; Itraconazole; Membrane Potentials; Microbial Sensitivity Tests; Phosphatidylserines; Reactive Oxygen Species; Rhizopus; Triazoles | 2013 |
N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
Topics: Acetylcysteine; Amphotericin B; Animals; Antifungal Agents; Brain; Creatinine; Cryptococcosis; Cryptococcus; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Repositioning; Female; Kidney; Lung; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Reactive Oxygen Species | 2020 |